A Win For scPharmaceuticals Inc.
Tue, Oct 11, 2022 at 07:52 PM
scPharmaceuticals Inc. (SCPH:NASDAQ) soared at $5.6, representing a gain of 39.3%. The stock appeared on our News Catalysts scanner on Mon, Oct 10, 2022 at 01:46 PM in the 'BIOTECH' category. From Tue, Sep 27, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About scPharmaceuticals Inc. (SCPH:NASDAQ)
scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 107.65%
- DICE Therapeutics Inc. (DICE:NASDAQ), 62.27%
- Immunic, Inc. (IMUX:NASDAQ), 51.77%
- ForgeRock Inc. Class A (FORG:NYSE), 48.55%
- Laser Photonics Corporation (LASE:NASDAQ), 44.39%
- scPharmaceuticals Inc. (SCPH:NASDAQ), 39.3%
- Oblong Inc. (OBLG:NASDAQ), 38.63%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 35.27%
- Meiwu Technology Company Limited (WNW:NASDAQ), 33.74%
- Agrify Corporation (AGFY:NASDAQ), 32.62%